479 related articles for article (PubMed ID: 18502503)
21. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
[TBL] [Abstract][Full Text] [Related]
22. l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma.
Heenan JM; Hooper AJ; Burnett JR; Cooney J
Pathology; 2021 Dec; 53(7):924-926. PubMed ID: 34049714
[No Abstract] [Full Text] [Related]
23. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
Charan VD; Desai N; Singh AP; Choudhry VP
Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
[No Abstract] [Full Text] [Related]
24. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
Parma M; Belotti D; Pogliani EM
Haematologica; 1996; 81(2):191. PubMed ID: 8641657
[No Abstract] [Full Text] [Related]
25. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
Salvador C; Meister B; Crazzolara R; Kropshofer G
Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
[No Abstract] [Full Text] [Related]
26. Asparaginase-associated pancreatitis in children.
Raja RA; Schmiegelow K; Frandsen TL
Br J Haematol; 2012 Oct; 159(1):18-27. PubMed ID: 22909259
[TBL] [Abstract][Full Text] [Related]
27. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
28. [The allograft in acute lymphoblastic leukemia].
Torlontano G; Di Girolamo G; Di Bartolomeo P; Angrilli F; Dragani A; Fioritoni G; Iacone A; D'Antonio D; Pomarici S; Amoroso A
Haematologica; 1989 Oct; 74(5 Suppl):433-42. PubMed ID: 2512227
[No Abstract] [Full Text] [Related]
29. [Clinical manifestation of toxic pancreas lesion in children with hematopoietic malignancies].
Balcerska A; Maciejka-Kapuścińska L; Kosiak W
Wiad Lek; 1998; 51 Suppl 4():90-6. PubMed ID: 10731949
[TBL] [Abstract][Full Text] [Related]
30. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
31. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia.
Chen CH; Lu MY; Lin KH; Lin DT; Peng SF; Jou ST
J Formos Med Assoc; 2004 May; 103(5):380-4. PubMed ID: 15216406
[TBL] [Abstract][Full Text] [Related]
32. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
[TBL] [Abstract][Full Text] [Related]
33. L-asparaginase-induced pancreatitis in children with acute lymphoblastic leukemia: is allopurinol protective?
Muwakkit S; Saab R; Yazbeck N; Samia L; Abboud MR
Pediatr Hematol Oncol; 2010 Sep; 27(6):496-501. PubMed ID: 20578808
[No Abstract] [Full Text] [Related]
34. Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
Maloney KW
Pediatr Blood Cancer; 2010 Feb; 54(2):189-90. PubMed ID: 19967774
[No Abstract] [Full Text] [Related]
35. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
37. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
38. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
[TBL] [Abstract][Full Text] [Related]
39. Peg-asparaginase for acute lymphoblastic leukemia.
Rytting M
Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
[TBL] [Abstract][Full Text] [Related]
40. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
Skomra S; Przybylska T
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
